Morbidity and mortality of coronavirus disease 2019 (COVID-19) are due in large part to
severe cytokine storm and hypercoagulable state brought on by dysregulated host …

Background Chest CT may be used for the diagnosis of coronavirus disease 2019 (COVID-
19), but clear scientific evidence is lacking. Therefore, we systematically reviewed and meta …

The objective of this review was to summarize the most pertinent CT imaging findings in
patients with coronavirus disease 2019 (COVID-19). A literature search retrieved eligible …

Introduction COVID-19 has an unpredictable clinical course, so prognostic biomarkers
would be invaluable when triaging patients on admission to hospital. Many biomarkers have …

Abstract Rationale: Coronavirus disease 2019 (COVID-19) was first announced in Wuhan,
and has rapidly evolved into a pandemic. However, the risk factors associated with the …

Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) emerged in
December 2019 in Wuhan province, China. SARS-CoV-2 causes coronavirus disease 2019 …

Objective: SARS-CoV-2 (originally named COVID-2019) pneumonia is currently prevalent
worldwide. The number of cases has increased rapidly but the auscultatory characteristics of …

Background Imaging-based quantitative assessment of lung lesions plays a key role in
patient triage and therapeutic decision-making processes. The aim of our study was to …

Although lung fibrosis has a major impact in COVID-19 disease, its pathogenesis is
incompletely understood. In particular, no direct evidence of pleura implication in COVID-19 …

Background This study aimed to determine the parameters for worsening oxygenation in
non-severe coronavirus disease 2019 (COVID-19) pneumonia. Methods This retrospective …